Skip to content
The Kids Research Institute Australia logo
Donate

No results yet

Search

Showing results for "1"

Research

Immunogenicity and Safety of a Quadrivalent Meningococcal ACWY-tetanus Toxoid Conjugate Vaccine 6 Years After MenC Priming as Toddlers

One dose of MenACWY-TT boosts protection against MenC in primed children, is safe and extends protection against MenA, MenW and MenY

Research

The Benefits to Bone Health in Children and Pre-School Children with Additional Exercise Interventions: A Systematic Review and Meta-Analysis

Determine if exercise interventions, beyond what is already provided to children and preschool children, improve bone health and reduce fracture incidence.

News & Events

Hypo awareness study

Young people are needed for a new study looking at ways to improve hypoglycaemia awareness through exercise.

Research

What constitutes cerebral palsy in the twenty-first century?

The aims of this paper were to (1) define inclusion/exclusion criteria that have been adopted uniformly by surveillance programmes and identify where...

Research fellows

Read about the research fellows at the Children's Diabetes Centre, Martin de Bock, Aveni Hayes, Ashleigh Lin and Marie-Anne Burckhardt.

News & Events

Mentor project gets the thumbs up

Young adult and parent peer mentors can be role models who not only normalise experiences of living with type 1 diabetes but can act as symbols of hope, new Children’s Diabetes Centre research has found.

News & Events

In other news ....

Diabetes-related news, funding announcements and our latest published research.

News & Events

Meat matters

Type 1 diabetes patients require about 50 per cent more insulin with a high protein meal then with a low protein meal to maintain a stable blood glucose level, according to new research from the Children’s Diabetes Centre at The Kids Research Institute Australia.

Research

CGM accuracy: Contrasting CE marking with the governmental controls of the USA (FDA) and Australia (TGA): A narrative review

The National Institute for Clinical Excellence updated guidance for continuous glucose monitoring (CGM) in 2022, recommending that CGM be available to all people living with type 1 diabetes. Manufacturers can trade in the UK with Conformité Européenne (CE) marking without an initial national assessment. The regulatory process for CGM CE marking, in contrast to the Food and Drug Administration (FDA) and Australian Therapeutic Goods Administration (TGA) process, is described.